Precision medicine in diffuse large B-cell lymphoma: hitting the target.
作者信息
Vermaat Joost S, Pals Steven T, Younes Anas, Dreyling Martin, Federico Massimo, Aurer Igor, Radford John, Kersten Marie José
机构信息
Department of Haematology, Academic Medical Center, Amsterdam, The Netherlands.
Department of Pathology, Academic Medical Center, Amsterdam, The Netherlands.
出版信息
Haematologica. 2015 Aug;100(8):989-93. doi: 10.3324/haematol.2015.128371.
Abstract
摘要
相似文献
1
Precision medicine in diffuse large B-cell lymphoma: hitting the target.弥漫性大B细胞淋巴瘤中的精准医学：命中靶点。
Haematologica. 2015 Aug;100(8):989-93. doi: 10.3324/haematol.2015.128371.
2
Precision medicine in diffuse large B-cell lymphoma: Hype or hope?弥漫性大B细胞淋巴瘤中的精准医学：炒作还是希望？
Eur J Cancer. 2016 Nov;68:22-26. doi: 10.1016/j.ejca.2016.08.025. Epub 2016 Sep 30.
3
Beyond genomics - Targeting the epigenome in diffuse large B-cell lymphoma.超越基因组学 - 在弥漫性大 B 细胞淋巴瘤中靶向表观基因组。
Cancer Treat Rev. 2017 Sep;59:132-137. doi: 10.1016/j.ctrv.2017.07.009. Epub 2017 Aug 9.
4
Diffuse Large B-cell lymphoma: Prognostic markers and their impact on therapy.弥漫性大 B 细胞淋巴瘤：预后标志物及其对治疗的影响。
Expert Rev Hematol. 2016 May;9(5):471-7. doi: 10.1586/17474086.2016.1146584. Epub 2016 Feb 19.
5
Precision Medicine for Diffuse Large B-cell Lymphoma.精准医学治疗弥漫性大 B 细胞淋巴瘤。
Clin Cancer Res. 2016 Jun 15;22(12):2829-31. doi: 10.1158/1078-0432.CCR-16-0232. Epub 2016 Mar 17.
6
Diffuse Large B-cell Lymphoma in the elderly: standard treatment and new perspectives.老年人弥漫性大 B 细胞淋巴瘤：标准治疗与新视角。
Expert Rev Hematol. 2017 Apr;10(4):289-297. doi: 10.1080/17474086.2017.1305264. Epub 2017 Mar 27.
7
Toward a New Molecular Taxonomy of Diffuse Large B-cell Lymphoma.迈向弥漫性大 B 细胞淋巴瘤新的分子分类学。
Cancer Discov. 2020 Sep;10(9):1267-1281. doi: 10.1158/2159-8290.CD-20-0174. Epub 2020 Jul 2.
8
Using the pathology report in initial treatment decisions for diffuse large B-cell lymphoma: time for a precision medicine approach.在弥漫性大B细胞淋巴瘤的初始治疗决策中使用病理报告：精准医学方法的时机已到。
Hematology Am Soc Hematol Educ Program. 2015;2015:618-24. doi: 10.1182/asheducation-2015.1.618.
9
Genomic stratification for the treatment of lymphomas.淋巴瘤治疗的基因组分层
Hematology Am Soc Hematol Educ Program. 2013;2013:331-4. doi: 10.1182/asheducation-2013.1.331.
10
Next-generation prognostic assessment for diffuse large B-cell lymphoma.弥漫性大B细胞淋巴瘤的下一代预后评估
Future Oncol. 2015;11(17):2443-57. doi: 10.2217/fon.15.144. Epub 2015 Aug 20.
引用本文的文献
1
Computational modelling of aggressive B-cell lymphoma.侵袭性B细胞淋巴瘤的计算建模
Biochem Soc Trans. 2025 Jul 4. doi: 10.1042/BST20253039.
2
Superior survival in diffuse large B cell lymphoma of the bone with immune rich tumor microenvironment.在具有免疫丰富肿瘤微环境的骨弥漫性大B细胞淋巴瘤中具有更高的生存率。
Blood Cancer J. 2025 Apr 29;15(1):82. doi: 10.1038/s41408-025-01291-z.
3
The Genetic Profile of Large B-Cell Lymphomas Presenting in the Ocular Adnexa.眼附属器大 B 细胞淋巴瘤的遗传学特征。
Int J Mol Sci. 2024 Mar 7;25(6):3094. doi: 10.3390/ijms25063094.
4
Real-world routine diagnostic molecular analysis for TP53 mutational status is recommended over p53 immunohistochemistry in B-cell lymphomas.推荐在 B 细胞淋巴瘤中进行真实世界常规诊断分子分析以检测 TP53 基因突变状态，而不是进行 p53 免疫组织化学检测。
Virchows Arch. 2024 Oct;485(4):643-654. doi: 10.1007/s00428-023-03676-6. Epub 2023 Oct 18.
5
Exploratory Genome-Wide Association Analysis to Identify Pharmacogenetic Determinants of Response to R-CHOP in Diffuse Large B-Cell Lymphoma.探索性全基因组关联分析以鉴定弥漫性大B细胞淋巴瘤中对R-CHOP治疗反应的药物遗传学决定因素。
Cancers (Basel). 2023 May 13;15(10):2753. doi: 10.3390/cancers15102753.
6
Biological and Clinical Implications of Gene-Expression Profiling in Diffuse Large B-Cell Lymphoma: A Proposal for a Targeted BLYM-777 Consortium Panel as Part of a Multilayered Analytical Approach.弥漫性大B细胞淋巴瘤基因表达谱分析的生物学及临床意义：作为多层分析方法一部分的靶向BLYM-777联合研究小组方案
Cancers (Basel). 2022 Apr 7;14(8):1857. doi: 10.3390/cancers14081857.
7
Frequent mutated B2M, EZH2, IRF8, and TNFRSF14 in primary bone diffuse large B-cell lymphoma reflect a GCB phenotype.原发性骨弥漫性大 B 细胞淋巴瘤中频繁突变的 B2M、EZH2、IRF8 和 TNFRSF14 反映了 GCB 表型。
Blood Adv. 2021 Oct 12;5(19):3760-3775. doi: 10.1182/bloodadvances.2021005215.
8
Mutational Profile and Clonal Evolution of Relapsed/Refractory Diffuse Large B-Cell Lymphoma.复发/难治性弥漫性大B细胞淋巴瘤的突变谱与克隆进化
Front Oncol. 2021 Mar 11;11:628807. doi: 10.3389/fonc.2021.628807. eCollection 2021.
9
IDO, TDO, and AHR overexpression is associated with poor outcome in diffuse large B-cell lymphoma patients in the rituximab era.在利妥昔单抗时代，吲哚胺2,3-双加氧酶（IDO）、色氨酸2,3-双加氧酶（TDO）和芳香烃受体（AHR）的过表达与弥漫性大B细胞淋巴瘤患者的不良预后相关。
Medicine (Baltimore). 2020 May 22;99(21):e19883. doi: 10.1097/MD.0000000000019883.
10
Using Informatics Tools to Identify Opportunities for Precision Medicine in Diffuse Large B-cell Lymphoma.利用信息学工具在弥漫性大 B 细胞淋巴瘤中寻找精准医学的机会。
Clin Lymphoma Myeloma Leuk. 2020 Apr;20(4):234-243.e10. doi: 10.1016/j.clml.2019.12.003. Epub 2019 Dec 24.
本文引用的文献
1
Diffuse large B-cell lymphoma: optimizing outcome in the context of clinical and biologic heterogeneity.弥漫性大 B 细胞淋巴瘤：在临床和生物学异质性的背景下优化治疗结局。
Blood. 2015 Jan 1;125(1):22-32. doi: 10.1182/blood-2014-05-577189. Epub 2014 Dec 11.
2
Personalized medicine in hematology - A landmark from bench to bed.血液学中的个性化医疗——从实验室到临床的一座里程碑。
Comput Struct Biotechnol J. 2014 Aug 8;10(17):70-7. doi: 10.1016/j.csbj.2014.08.002. eCollection 2014 Jul.
3
Precision therapy for lymphoma--current state and future directions.淋巴瘤精准治疗——现状与未来方向。
Nat Rev Clin Oncol. 2014 Oct;11(10):585-96. doi: 10.1038/nrclinonc.2014.137. Epub 2014 Aug 19.
4
Genetics of diffuse large B-cell lymphoma: paving a path to personalized medicine.弥漫性大B细胞淋巴瘤的遗传学：为个性化医疗铺平道路。
Cancer J. 2014 Jan-Feb;20(1):43-7. doi: 10.1097/PPO.0000000000000014.
5
Accelerated therapeutic progress in diffuse large B cell lymphoma.弥漫性大 B 细胞淋巴瘤的治疗进展加速。
Ann Hematol. 2014 Apr;93(4):541-56. doi: 10.1007/s00277-013-1979-7. Epub 2013 Dec 28.
6
Diffuse large B-cell lymphoma-treatment approaches in the molecular era.弥漫性大 B 细胞淋巴瘤的分子时代治疗方法。
Nat Rev Clin Oncol. 2014 Jan;11(1):12-23. doi: 10.1038/nrclinonc.2013.197. Epub 2013 Nov 12.
7
Molecular classification, pathway addiction, and therapeutic targeting in diffuse large B cell lymphoma.弥漫性大B细胞淋巴瘤的分子分类、通路成瘾及治疗靶点
Cancer Genet. 2013 Jul-Aug;206(7-8):257-65. doi: 10.1016/j.cancergen.2013.07.003. Epub 2013 Sep 27.
8
Genome sequencing of lymphoid malignancies.淋巴恶性肿瘤的基因组测序。
Blood. 2013 Dec 5;122(24):3899-907. doi: 10.1182/blood-2013-08-460311. Epub 2013 Sep 16.
9
Massively parallel sequencing: the new frontier of hematologic genomics.大规模平行测序：血液基因组学的新前沿。
Blood. 2013 Nov 7;122(19):3268-75. doi: 10.1182/blood-2013-07-460287. Epub 2013 Sep 10.
10
Clonal evolution in hematological malignancies and therapeutic implications.血液系统恶性肿瘤中的克隆进化及治疗意义。
Leukemia. 2014 Jan;28(1):34-43. doi: 10.1038/leu.2013.248. Epub 2013 Aug 27.
Zotero 插件